Please try another search
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Name | Age | Since | Title |
---|---|---|---|
Razelle Kurzrock | - | 2017 | Member of Scientific Advisory Board |
Andrew Hendifar | - | 2017 | Member of Scientific Advisory Board |
Alexander Knuth | - | 2017 | Member of Scientific Advisory Board |
Peter Libby | 74 | 2018 | Member of Scientific Advisory Board & Independent Director |
Alice B. Gottlieb | - | 2018 | Member of Scientific Advisory Board |
Mark E. Rupp | - | - | Member of Scientific Advisory Board |
John Simard | 59 | 2005 | Founder, President, CEO & Chairman |
W. Thorpe McKenzie | 72 | 2009 | Independent Director |
Evangelos J. Giamarellos-Bourboulis | - | - | Member of Scientific Advisory Board |
Donald H. MacAdam | 77 | 2018 | Independent Director |
Jan-Paul Waldin | 75 | 2018 | Lead Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review